Global Trypsin Market Projected to Hit USD 147.46 Million by 2032, Fueled by Biopharma Demand and Growing Applications | S&S Insider

Market Overview: The Trypsin Market was valued at USD 90.31 million in 2023 and is projected to grow to USD 147.46 million by 2032, with a CAGR of 5.62% driven by demand in biopharmaceuticals, cell culture, food processing, and cosmetics.

Key Drivers: Factors such as the rising incidence of chronic diseases, increased adoption of biologics, and government initiatives like the FDA’s accelerated approval pathways are significantly boosting the trypsin market.

Regional Insights: North America leads the market with a 39.46% share in 2023, supported by strong biopharmaceutical R&D and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region due to rising investments in biopharmaceuticals.

Industry Applications: Trypsin is primarily used in the biotechnology and pharmaceutical sectors for cell culture and vaccine development, as well as in food processing and industrial applications, with a notable shift towards recombinant trypsin for its purity and reduced contamination risks.